Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria flag Nigeria · Delayed Price · Currency is NGN
9.20
0.00 (0.00%)
At close: Apr 14, 2026

NGX:NEIMETH Income Statement

Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Sep '22
7,3694,4852,2102,9192,703
Revenue Growth (YoY)
64.29%102.98%-24.31%8.01%-11.29%
Cost of Revenue
4,3352,5501,5001,8861,629
Gross Profit
3,0331,936709.151,0331,074
Selling, General & Admin
1,8001,2861,6361,2041,125
Other Operating Expenses
-935.85-1,183-1,225-157.95-26.15
Operating Expenses
863.83103.7410.421,0461,099
Operating Income
2,1691,832298.73-12.39-24.8
Interest Expense
-1,322-873.32-667.95-300-181.77
Interest & Investment Income
249.57231.39129.23--
Currency Exchange Gain (Loss)
214.85-2,048-1,4511.9496.89
EBT Excluding Unusual Items
1,312-858.03-1,691-310.45-109.67
Gain (Loss) on Sale of Assets
1.23.60.97--
Pretax Income
1,313-854.43-1,690-310.44-109.66
Income Tax Expense
336.530.9107.8814.6-
Net Income
976.42-885.33-1,798-325.04-109.66
Net Income to Common
976.42-885.33-1,798-325.04-109.66
Shares Outstanding (Basic)
4,2734,2734,2731,8991,899
Shares Outstanding (Diluted)
4,2734,2734,2731,8991,899
Shares Change (YoY)
--125.00%--
EPS (Basic)
0.23-0.21-0.42-0.17-0.06
EPS (Diluted)
0.23-0.21-0.42-0.17-0.06
Free Cash Flow
1,229-306.71-1,710-1,137-1,205
Free Cash Flow Per Share
0.29-0.07-0.40-0.60-0.63
Gross Margin
41.16%43.16%32.09%35.39%39.74%
Operating Margin
29.44%40.84%13.52%-0.43%-0.92%
Profit Margin
13.25%-19.74%-81.35%-11.13%-4.06%
Free Cash Flow Margin
16.68%-6.84%-77.37%-38.95%-44.57%
EBITDA
2,3341,962424.8296.0294.78
EBITDA Margin
31.68%43.74%19.23%3.29%3.51%
D&A For EBITDA
164.91129.99126.09108.41119.57
EBIT
2,1691,832298.73-12.39-24.8
EBIT Margin
29.44%40.84%13.52%-0.42%-0.92%
Effective Tax Rate
25.63%----
Advertising Expenses
314.07192.93363.67-188.49
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.